Markus Altmann

Markus Altmann is a seasoned professional with extensive experience as a senior director in global and regional medical affairs, specializing in autoimmune diseases like neurology, dermatology, and rheumatology, along with expertise in hematology and solid tumors.

He is recognized as a strategic, inspirational, and empowering leader, adept at managing large teams in both direct and matrix structures.

Markus possesses in-depth knowledge of various European reimbursement systems, with a particular focus on AMNOG.

His strengths lie in the pre-launch phase, where he excels at building and leading medical teams and organizations through the life cycle of a drug.

Known for his strong networking skills, Markus is well-connected across different indication areas at a peer-to-peer level, fostering global key opinion leaders (KOLs) into advocates and partners.

He is characterized as open-minded, always eager to learn and tackle new challenges.

Markus Altmann holds a Promotion degree in Biologie and a Diplom-Ingenieurin (Dipl.Ing.) degree in Biologie, both from Ludwig-Maximilians Universit"at M"unchen.

In terms of professional experience, he has served as a senior medical director for Germany, Austria, and Switzerland at Seattle Genetics.

Previously, Markus held positions as Senior Director of Medical Affairs EMEA therapeutic lead for multiple sclerosis, Director of Medical Affairs and Clinical Research for Immunology and Inflammation, Associate European Medical Lead for Oncology, Medical Advisor/Disease Area Specialist for Oncology, and Medical Science Manager for Immunology, among others.

His background also includes experience as a Gruppenleiter Forschung at Deutsche Helmholtz Gesellschaft.